Hypoxia-Selective Targeting by the Bioreductive Prodrug AQ4N in Patients with Solid Tumors: Results of a Phase I Study
Year: 2008
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Institutions: University of Bradford, Hutchison/MRC Research Centre, Medical Research Council, Beatson West of Scotland Cancer Centre, University of Cambridge, Addenbrooke's Hospital, John Radcliffe Hospital, University of Leeds, Cancer Research UK, St James's University Hospital, Pauls Stradiņš Clinical University Hospital
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2155826289
